IP Library Assignment 056472/0201
Patent Assignment
Reel/Frame 056472/0201

Assignment of Assignor's Interest

Recorded: 2021-06-08 Pages: 5
Assignors
SCHNEIDER, STEPHEN
Executed: 2020-06-16
WHITE, HANNAH
Executed: 2020-01-16
Assignee
G1 THERAPEUTICS, INC.
700 PARK OFFICES DRIVE, SUITE 200, RESEARCH PARK TRIANGLE, NORTH CAROLINA, 27709
Covered Property (1)
Synthesis of 1,4-Diazaspiro[5.5]Undecan-3-One
Application: 17/184,354 →
Publication: US 2021/0179567
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 8, 2021
From: FESSARD, THOMAS; BELDAR, SAGAR
To: SPIROCHEM AG
Reel/Frame 056472/0212 →
Assignment of Assignor's Interest Jun 8, 2021
From: SPIROCHEM AG
To: G1 THERAPEUTICS, INC.
Reel/Frame 056472/0227 →
Corrective Assignment to Correct the First Conveying Party's Execution Date Previously Recorded at Reel: 056472 Frame: 0201. Assignor(S) Hereby Confirms the Assignment. Jun 17, 2021
From: SCHNEIDER, STEPHEN; WHITE, HANNAH
To: G1 THERAPEUTICS, INC.
Reel/Frame 056618/0483 →
Assignment of Assignor's Interest Dec 5, 2024
From: G1 THERAPEUTICS, INC.
To: PHARMACOSMOS A/S
Reel/Frame 069502/0159 →
Assignment of Assignor's Interest Dec 5, 2024
From: PHARMACOSMOS A/S
To: PHARMACOSMOS HOLDING A/S
Reel/Frame 069502/0179 →